---
title: HR 1524. General Assembly; reschedule marijuana from a Schedule I substance to a Schedule III substance in accordance with presidential Executive Order 14370; urge
collection: bills
id: 2025-2026/hr1524
cite_as: HR 1524, 2025-2026 Regular Session (Ga.)
canonical_url: https://georgiacommons.org/bills/2025-2026/hr1524
md_url: https://georgiacommons.org/bills/2025-2026/hr1524.md
text_url: https://georgiacommons.org/bills/2025-2026/hr1524/text
source_url: https://www.legis.ga.gov/legislation/73781
date: 2026-03-06
status: introduced
corpus_version: bills-2026-09-13
license: Public record of the Georgia General Assembly, via LegiScan; see about.md
publisher: Georgia Commons, an independent project of Georgia Civic Data. Not the State of Georgia. Not legal advice.
up: https://georgiacommons.org/bills/2025-2026.md
previous: https://georgiacommons.org/bills/2025-2026/hr1523.md
next: https://georgiacommons.org/bills/2025-2026/hr1525.md
index: https://georgiacommons.org/bills/index.md
omitted: votes and history
omitted_chars: 129
omitted_url: https://georgiacommons.org/bills/2025-2026/hr1524.md?full=1
bill_number: HR 1524
session: 2025-2026 Regular Session
session_slug: 2025-2026
chamber: House
bill_type: resolution
status_date: 2026-03-03
last_action: House Second Readers
sponsors:
  - Eric Bell
  - Derrick Jackson
  - El-Mahdi Holly
  - Spencer Frye
  - Samuel Park
text_version: Introduced
has_text: true
legiscan_url: https://legiscan.com/GA/bill/HR1524/2025
upstream_id: 2128594
summaries_model: claude-sonnet-5
topic_tags:
  - marijuana rescheduling
  - medical marijuana
  - drug policy
  - cannabis research
---

# HR 1524. General Assembly; reschedule marijuana from a Schedule I substance to a Schedule III substance in accordance with presidential Executive Order 14370; urge

## Text

House Resolution 1524
By: Representatives Bell of the 75th, Jackson of the 68th, Holly of the 116th, Frye of the 122nd,
and Park of the 107th
A RESOLUTION
Urging the Georgia General Assembly to reschedule marijuana from a Schedule I substance
to a Schedule III substance in accordance with presidential Executive Order 14370; and for
other purposes.
WHEREAS, in 2023, the Food and Drug Administration (FDA) completed a review of the
landscape of medical use of marijuana and found scientific support for its use to treat
anorexia related to a medical condition, nausea and vomiting, and pain; and
WHEREAS, Chronic pain affects nearly one and four adults and more than one in three
seniors in the United States, and six in ten people who use medical marijuana report doing
so to manage pain; and
WHEREAS, approximately 40 states including the District of Columbia have state or locally
sanctioned, regulated medical marijuana programs; and
WHEREAS, marijuana is currently controlled under Schedule I of the Controlled Substances
Act (CSA). In 2023, the Department of Health and Human Services (HHS) recommended
to the Drug Enforcement Agency that marijuana be controlled under Schedule III of the
CSA; and
WHEREAS, Schedule I drugs are classified as drugs with no currently accepted medical use,
a high potential for abuse, and a lack of accepted safety for use under medical supervision;
and
WHEREAS, Schedule III drugs are classified as drugs with less potential for abuse than the
drugs or other substances in Schedules I and II, having a currently accepted medical use in
treatment in the United States, and a potential for moderate or low physical dependence or
high psychological dependence in the event of drug abuse; and
WHEREAS, the recommendation from HHS included a determination that medical
marijuana has a currently accepted medical use. Such determination was based in part on a
finding by the HHS Office of the Assistant Secretary of Health that more than 30,000
licensed healthcare practitioners across 43 United States jurisdictions are authorized to
recommend the medical use of marijuana for more than six million registered patients to treat
at least 15 medical conditions; and
WHEREAS, findings by the FDA support the use of marijuana in the treatment of pain,
anorexia related to certain medical conditions, and nausea and vomiting induced by
chemotherapy, and the National Institute on Drug Abuse concurred with the FDA's
recommendation that marijuana be rescheduled from Schedule I to Schedule III of the CSA;
and
WHEREAS, in May 2024, the Department of Justice issued a proposed rule to reschedule
marijuana to Schedule III. The proposed rule received nearly 43,000 public comments and
is currently awaiting an administrative law hearing; and
WHEREAS, with the presidential executive order on December 18, 2025, regarding
"Increasing Medical Marijuana and Cannabidiol Research" directed that the United States
Attorney General shall take all appropriate actions to complete the rule-making process
related to rescheduling marijuana to Schedule III of the CSA in the most expeditious manner
in accordance with federal law, including 21 U.S.C. Section 811; and
WHEREAS, the House of Representatives is committed to increasing medical marijuana and
cannabidiol research to better inform patients and doctors for the United States and the State
of Georgia.
NOW, THEREFORE, BE IT RESOLVED BY THE HOUSE OF REPRESENTATIVES that
the members of this body urge the Georgia General Assembly to expeditiously reschedule
marijuana from a Schedule I substance to a Schedule III substance and take any and all
necessary steps to increase medical marijuana and cannabidiol research to better inform
patients and doctors.
BE IT FURTHER RESOLVED that the Speaker of the House of Representatives is
authorized and directed to make an appropriate copy of this resolution available for
distribution to the Georgia General Assembly.

## Summaries written by Georgia Commons

The following was written by claude-sonnet-5 from the text above and is not part of the resolution. Quote the text, not the summary.

A Georgia House resolution urges the General Assembly to reclassify marijuana from a Schedule I to a Schedule III controlled substance, mirroring a pending federal rescheduling effort.

### Plain-language summary

This resolution does not change any Georgia law itself. Instead, it expresses the House of Representatives' position that the General Assembly should act to move marijuana from Schedule I to Schedule III under Georgia's drug scheduling system, matching a federal effort already underway through the U.S. Department of Justice and a December 2025 presidential executive order.
The resolution cites federal findings, including a 2023 FDA review supporting marijuana's medical use for pain, nausea, and appetite loss, and a Department of Health and Human Services recommendation to reschedule it federally. It notes that about 40 states already have medical marijuana programs. The resolution urges lawmakers to move quickly on rescheduling and to support more research into medical marijuana and cannabidiol, and directs the Speaker of the House to distribute copies of the resolution to the General Assembly.

### What it does

- Formally urges the Georgia General Assembly to reschedule marijuana from Schedule I to Schedule III of the state's controlled substances classification.
- Calls on lawmakers to take steps to increase research into medical marijuana and cannabidiol to better inform patients and doctors.
- Directs the Speaker of the House to make copies of the resolution available for distribution to the General Assembly.
- Does not itself amend any Georgia statute; it expresses the House's position rather than enacting a binding legal change.

### Who it affects

Georgia lawmakers who would need to act on any future rescheduling legislation, patients and doctors involved in medical marijuana treatment, and state agencies that regulate controlled substances. It does not directly change rules for law enforcement, businesses, or individuals unless further legislation follows.

### Why it matters

Because this is a resolution rather than a law, it does not change what is legal in Georgia. But it signals House support for reclassifying marijuana, which could pave the way for future legislation affecting medical marijuana access, research funding, and how the drug is treated under state law.

### Key provisions

- Recites federal findings from the FDA, HHS, and National Institute on Drug Abuse supporting reclassification of marijuana from Schedule I to Schedule III.
- References the Department of Justice's May 2024 proposed federal rule to reschedule marijuana and a December 18, 2025 presidential executive order directing expedited federal action.
- States that the House of Representatives resolves to urge the General Assembly to reschedule marijuana and pursue increased medical marijuana and cannabidiol research.
- Directs the Speaker of the House to distribute copies of the resolution to the General Assembly.

## Status

- Status: Introduced (2026-03-03)
- Last action: House Second Readers (2026-03-06)
- Sponsors: Eric Bell, Derrick Jackson, El-Mahdi Holly, Spencer Frye, Samuel Park
- Official page: https://www.legis.ga.gov/legislation/73781

> The history, votes, and amendments (129 characters) are at https://georgiacommons.org/bills/2025-2026/hr1524.md?full=1